DVT of lower extremities

I9_PHLETHROMBDVTLOW

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I80.1#, I80.20#, I80.29# Hospital discharge: ICD-9 — 4511A Cause of death: ICD-10 — I80.1#, I80.20#, I80.29# Cause of death: ICD-9 — 4511A 2 out of 7 registries used, show all original rules.	8367
4. Check minimum number of events None	8367
5. Include endpoints None	8367
6. Filter based on genotype QC (FinnGen only)	8367

Control definitions (FinnGen only)

Control exclude: I9_DISVEINLYMPH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF10

NAME	I9_PHLETHROMBDVTLOW
CONTROL_EXCLUDE	I9_DISVEINLYMPH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I80[12]
HD_ICD_9	4511A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I80[12]
COD_ICD_9	4511A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to DVT of lower extremities based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	75938	40582	34466
Only index persons	57445	31327	26118
Unadjusted period prevalence (%)
Whole population	1.07	1.16	0.96
Only index persons	1.08	1.15	1.00
Median age at first event (years)
Whole population	64.23	66.20	61.83
Only index persons	61.18	62.72	59.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8367	4302	4065
Unadjusted period prevalence (%)	1.62	1.47	1.79
Median age at first event (years)	59.00	57.33	60.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7470: Matched controls
74699

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

897.0

323.0

4452

122

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

23.1

323.0

718

343

M79.6

ICD-10 Finland

Pain in limb

2.8

323.0

3337

16610

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

11.8

323.0

1060

1036

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

14.4

323.0

2819

3017

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

91.8

323.0

653

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

1306.0

323.0

1867

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

45.5

323.0

1102

283

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

323.0

401

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

323.0

1241

B01AB05

ATC

enoxaparin; parenteral

5.8

323.0

4268

14038

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

143.0

323.0

593

B01AA03

ATC

warfarin; systemic

8.8

323.0

4168

9413

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

323.0

329

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

36.0

323.0

812

252

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

1606.3

323.0

583

B01AF01

ATC

rivaroxaban; oral

4.2

323.0

1633

4620

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

86.4

323.0

416

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

24.1

323.0

1403

710

PHD99

NOMESCO Finland

Resection of other vein

743.4

323.0

422

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

9.3

323.0

1266

1598

K94

ICPC

Phlebitis/thrombophlebitis

40.4

323.0

587

157

PHD76

NOMESCO Finland

Resection of long saphenous vein

1033.0

306.1

298

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

96.1

282.7

313

B01AB04

ATC

dalteparin; parenteral

5.6

255.7

808

1586

R60.0

ICD-10 Finland

Localized oedema

3.6

255.5

1297

4065

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

249.3

238

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

267.6

228.6

233

B01AF02

ATC

apixaban; oral

3.4

216.1

1188

3923

D68.8

ICD-10 Finland

Other specified coagulation defects

28.2

213.8

296

109

B01AB10

ATC

tinzaparin; parenteral

4.1

202.7

863

2290

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

201.5

927

2636

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

191.4

183

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

24.4

188.0

271

115

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

24.7

183.2

263

110

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

26.6

165.1

232

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

8.2

160.3

374

476

A46

ICD-10 Finland

Erysipelas

2.6

157.8

1327

5699

I87.0

ICD-10 Finland

Postthrombotic syndrome

528.9

157.4

156

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

18.3

149.2

236

133

N02AX02

ATC

tramadol; systemic, rectal

1.9

143.2

3339

22354

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

142.4

1211

5201

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

141.2

3429

23247

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

5.3

129.2

418

826

C03CA01

ATC

furosemide; systemic

1.9

127.1

2519

15707

L17

ICPC

Foot/toe symptom/complaint

2.0

123.8

1939

11034

N02AA05

ATC

oxycodone; systemic

2.3

123.7

1342

6498

K93

ICPC

Pulmonary embolism

12.6

122.7

226

185

N02BE01

ATC

paracetamol; systemic, rectal

2.0

117.3

6297

54162

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

1156.3

117.0

114

L14

ICPC

Leg/thigh symptom/complaint

3.0

109.1

682

2399

J01DB01

ATC

cefalexin; oral

1.8

106.6

5813

49007

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

12.7

99.7

182

146

5612

FHL

Local excisions and / or perforations of relapsing varicose veins

253.5

97.9

100

R06.0

ICD-10 Finland

Dyspnoea

1.8

93.3

1922

11869

N03AX16

ATC

pregabalin; oral

1.8

89.1

1769

10756

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

89.0

2581

17686

A02BC02

ATC

pantoprazole; systemic

1.6

88.3

4655

37520

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

87.0

1123

5791

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

+∞

86.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

85.8

3215

23596

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

85.5

2262

15043

H02AB06

ATC

prednisolone; systemic

1.6

85.3

3363

25001

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

10.3

83.9

170

169

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

83.0

1344

7575

I26

ICD-10 Finland

Pulmonary embolism

9.7

82.3

172

181

J01FF01

ATC

clindamycin; systemic

1.7

80.8

1944

12517

K99

ICPC

Cardiovascular disease other

4.1

78.5

325

823

L28

ICPC

Limited function/disability (L)

1.9

77.2

1252

7038

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

73.3

1253

7165

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

+∞

73.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

73.0

2343

16291

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

72.4

1038

5551

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

71.9

1545

9541

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

70.0

880

4457

J01MA12

ATC

levofloxacin; systemic

1.8

69.7

1397

8426

S97

ICPC

Chronic ulcer skin

2.9

69.2

459

1662

A08

ICPC

Swelling

3.2

67.9

379

1223

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

67.1

420

1466

PHD78

NOMESCO Finland

Resection of communicating veins of lower leg and thigh

+∞

66.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

65.9

1841

12248

SPAT1229

SPAT

Assessment of need for aid

2.3

64.5

677

3156

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

63.3

2036

14044

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

62.0

2348

16859

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

61.2

1259

7618

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

59.5

1495

9607

JN4BD

NOMESCO Finland

Extensive body CT

2.0

58.9

872

4697

S18

ICPC

Laceration/cut

1.5

58.8

2854

21648

I82

ICD-10 Finland

Other venous embolism and thrombosis

26.4

58.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

57.3

1251

7696

ZXD05

NOMESCO Finland

Urgent procedure

1.6

56.7

2138

15260

PHD77

NOMESCO Finland

Resection of short saphenous vein

+∞

56.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.0

56.3

838

4521

SPAT1263

SPAT

Sampling

1.5

56.1

2853

21792

J01MA02

ATC

ciprofloxacin; systemic

1.5

56.0

2718

20548

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

55.4

979

5616

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

55.3

1902

13255

I81

ICD-10 Finland

Portal vein thrombosis

283.6

55.3

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

55.1

1450

9415

SPAT1254

SPAT

Administration of medicine

1.8

54.3

1071

6371

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

53.5

403

1576

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

53.2

795

4288

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

53.1

2084

14965

AA1AD

NOMESCO Finland

CT of head and brain

1.6

52.8

1717

11774

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

+∞

52.1

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

51.3

495

2208

H02AB02

ATC

dexamethasone; systemic

2.0

51.1

741

3950

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

177.9

50.9

J01DA01

ATC

[U] cefalexin; systemic

1.4

50.7

4249

35645

M54.5

ICD-10 Finland

Low back pain

1.5

50.7

2068

14951

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

25.6

50.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

50.6

747

4007

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

6.0

50.6

144

244

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

50.5

647

3282

A28

ICPC

Limited function/disability NOS

1.7

50.3

1142

7081

M04AA01

ATC

allopurinol; systemic

1.8

50.3

1005

5991

R50.9

ICD-10 Finland

Fever, unspecified

1.8

49.8

940

5497

M25.5

ICD-10 Finland

Pain in joint

1.6

49.6

1753

12242

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

49.4

959

5662

UJF32

NOMESCO Finland

Coloscopy

1.6

48.5

1773

12471

X58

ICD-10 Finland

Exposure to other specified factors

1.8

48.4

878

5064

K07

ICPC

Swollen ankles/oedema

2.7

48.0

355

1373

PHB78

NOMESCO Finland

Ligature of perforating veins of lower extremity

+∞

48.0

L15

ICPC

Knee symptom/complaint

1.6

47.7

1322

8662

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

47.6

2437

18454

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

47.2

286

976

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

46.7

560

2758

5613

FHL

Conjunctival occlusion

161.0

45.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

45.8

993

6059

A04AA01

ATC

ondansetron; systemic, rectal

2.2

45.7

478

2214

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

11.6

45.7

N03AX12

ATC

gabapentin; oral

1.7

45.7

1035

6397

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

45.4

1102

6948

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

45.3

1756

12486

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

+∞

44.8

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

23.5

44.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

43.9

2073

15372

D68.9

ICD-10 Finland

Coagulation defect, unspecified

15.8

43.8

ZXA05

NOMESCO Finland

Left side

1.5

43.8

1763

12629

R4110

NOMESCO Finland

Physiotherapy

1.5

43.4

1768

12692

I83

ICD-10 Finland

Varicose veins of lower extremities

5.6

43.1

129

233

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

221.2

42.9

B01AX05

ATC

fondaparinux; parenteral

6.3

42.9

117

188

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

80.6

42.9

SPAT1216

SPAT

Assessment of functional ability

1.7

42.5

1099

7043

R53

ICD-10 Finland

Malaise and fatigue

1.6

41.9

1373

9357

R03AC02

ATC

salbutamol; inhalant

1.4

41.8

3333

27271

SPAT1255

SPAT

Intravenous administration of medicine

2.1

41.8

484

2347

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

41.8

894

5421

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

40.9

1139

7441

Z3226

NOMESCO Finland

Physiotherapist

1.6

40.8

1226

8168

R52.9

ICD-10 Finland

Pain, unspecified

2.0

40.6

576

3031

SPAT1211

SPAT

Application of soft bandage

1.9

40.4

620

3363

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

39.9

1151

7583

R51.80

ICD-10 Finland

Headache

1.7

39.8

848

5131

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

39.6

1148

7575

J01FA06

ATC

roxithromycin; oral

1.4

39.4

2662

21070

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

39.0

464

2275

E0000UV

ATC

1.4

38.8

2425

18899

PH2AE

SPAT

5.9

38.4

110

189

UKC02

NOMESCO Finland

Cystoscopy

1.6

38.2

1127

7460

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

379.3

38.1

WX110

NOMESCO Finland

Local anesthesy

1.4

37.9

4293

37039

K78

ICPC

Atrial fibrillation/flutter

1.9

37.7

575

3110

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

37.5

439

2138

Z51.5

ICD-10 Finland

Palliative care

2.1

37.3

465

2323

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

37.3

536

2836

J01AA02

ATC

doxycycline; systemic

1.4

37.3

5324

47716

L16

ICPC

Ankle symptom/complaint

1.9

36.9

607

3372

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

36.9

1049

6874

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

36.9

1863

13908

M79.1

ICD-10 Finland

Myalgia

1.7

36.8

767

4604

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

36.4

3091

25344

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

36.1

653

3746

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

35.9

2429

19137

M10.9

ICD-10 Finland

Gout, unspecified

2.0

35.7

483

2496

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

35.1

417

2039

H02AB04

ATC

methylprednisolone; systemic

1.6

34.8

960

6235

H02AB07

ATC

prednisone; oral

1.6

34.8

967

6293

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

34.7

919

5903

A06AD11

ATC

lactulose; oral

1.6

34.4

1035

6870

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

34.4

1052

7009

ZXA00

NOMESCO Finland

Right side

1.4

34.4

1804

13533

M01AH02

ATC

rofecoxib; oral

1.6

34.3

898

5747

P01AB01

ATC

metronidazole; oral, rectal

1.4

34.1

2401

19003

PHB76

NOMESCO Finland

Ligature of long saphenous vein

338.7

33.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

33.8

529

2884

N30.0

ICD-10 Finland

Acute cystitis

1.6

33.6

867

5528

Z3231

NOMESCO Finland

Registered nurse

1.4

33.3

1780

13387

JN4AD

NOMESCO Finland

Body CT examination

1.9

33.2

531

2918

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

33.0

338

1551

J01CA04

ATC

amoxicillin; systemic

1.4

32.8

5218

46966

SPAT1301

SPAT

No procedures

1.4

32.7

2058

15942

E66.8

ICD-10 Finland

Other obesity

2.3

32.5

303

1329

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

32.1

434

2236

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

31.9

991

6622

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

318.4

31.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

31.8

1323

9446

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

165.7

31.7

130

Kela drug reimbursment

Malignant tumour

1.8

31.7

589

3406

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

31.6

1324

9470

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

31.5

2469

19831

G47.3

ICD-10 Finland

Sleep apnoea

1.5

31.4

1287

9156

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

31.4

726

4485

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

31.3

1133

7845

K95

ICPC

Varicose veins of leg

6.1

31.3

145

PHG76

NOMESCO Finland

Intraluminal laser vein occlusion of long saphenous vein

+∞

31.3

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

31.2

672

4066

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

30.9

763

4802

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

30.7

155

467

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

12.0

30.6

ZX120

NOMESCO Finland

Intravenous

1.8

30.5

613

3629

K28

ICPC

Limited function/disability (K)

3.0

30.3

178

597

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

30.3

2448

19728

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

29.9

1159

8141

WX002

NOMESCO Finland

Sedation and analgesia

1.5

29.9

1248

8906

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

29.8

493

2741

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

29.7

684

4217

A01

ICPC

Pain general/multiple sites

1.9

29.6

489

2715

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.6

29.5

227

899

L03

ICPC

Low back symptom/complaint

1.4

29.4

1399

10250

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

29.2

2249

17955

A02BC05

ATC

esomeprazole; systemic

1.3

29.1

2554

20815

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

29.1

429

2285

R31

ICD-10 Finland

Unspecified haematuria

1.7

28.9

678

4202

S29

ICPC

Skin symptom/complaint other

1.5

28.9

1020

7011

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

28.6

580

3444

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

28.2

483

2713

K29

ICPC

Cardiovascular sympt/complt other

2.2

28.2

301

1405

M01AX17

ATC

nimesulide; oral

1.4

28.1

1597

12087

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

31.0

28.1

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

28.0

1633

12414

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

28.0

430

2328

Z71.8

ICD-10 Finland

Other specified counselling

1.4

27.7

1337

9806

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

27.7

2454

19991

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

27.6

321

1555

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

27.6

397

2098

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

27.6

601

3643

ZXE00

NOMESCO Finland

One hour or less

1.3

27.2

2465

20137

M02AA07

ATC

piroxicam; topical

1.3

27.0

2427

19795

A29

ICPC

General symptom/complaint other

1.6

26.9

706

4507

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

26.9

455

2544

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.9

26.8

113

294

S80.0

ICD-10 Finland

Contusion of knee

2.0

26.7

373

1950

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

26.6

484

2775

127

Kela drug reimbursment

Transplant complication

3.7

26.6

119

326

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

26.4

1008

7036

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

26.2

684

4358

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

26.1

112

296

M03BX02

ATC

tizanidine; oral

1.3

26.1

3764

32782

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

25.4

195

773

WX320

NOMESCO Finland

Spinalanesthesy

1.4

25.4

1391

10432

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

25.4

625

3921

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

25.4

414

2290

J01MA14

ATC

moxifloxacin; systemic

1.7

25.3

563

3429

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

25.2

1202

8778

M02AA10

ATC

ketoprofen; topical

1.5

25.2

988

6936

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

25.2

292

1416

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.6

25.1

194

772

4540A

ICD-9 Finland

Varicose veins of lower extremities, With ulcer

+∞

25.0

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

25.0

874

5981

R52.0

ICD-10 Finland

Acute pain

2.6

24.8

188

739

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

24.8

247

1119

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

24.7

664

4262

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

251.0

24.7

A02BC01

ATC

omeprazole; systemic

1.4

24.4

1788

14078

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

24.4

190

761

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

24.3

198

809

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

48.5

24.2

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

24.2

483

2850

J01FA10

ATC

azithromycin; systemic

1.3

24.1

3336

28771

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

24.0

1133

8252

L04AA06

ATC

mycophenolic acid; systemic

3.3

24.0

124

382

M01AB05

ATC

diclofenac; systemic, rectal

1.3

23.9

4230

37648

J01EA01

ATC

trimethoprim; systemic

1.4

23.9

1544

11900

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

23.8

412

2322

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

23.7

924

6468

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

23.7

412

2326

PHL76

NOMESCO Finland

Ultrasound guided foam sclerotherapy of long saphenous vein

240.7

23.6

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

87.0

23.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

23.6

173

669

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

23.5

521

3171

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

23.4

286

1416

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

23.4

836

5742

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

23.3

264

1266

WZC30

NOMESCO Finland

Teaching

1.5

23.3

807

5506

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

23.2

4236

37782

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

11.4

23.1

J01CA08

ATC

pivmecillinam; oral

1.3

23.0

2268

18639

M01AE02

ATC

naproxen; oral, rectal

1.3

23.0

3437

29869

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

23.0

2775

23453

PH7UT

NOMESCO Finland

Removal of thrombosis from vein of lower extremity or pelvis or from vena cava inferior

+∞

22.9

A02BC03

ATC

lansoprazole; oral

1.3

22.8

1853

14795

R42

ICD-10 Finland

Dizziness and giddiness

1.4

22.7

1379

10510

WX892

NOMESCO Finland

Monitored bed care

1.7

22.7

476

2853

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

22.7

1103

8073

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

22.6

494

2994

M48.0

ICD-10 Finland

Spinal stenosis

1.5

22.6

798

5465

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

230.6

22.6

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

22.6

192

806

R06AE07

ATC

cetirizine; oral

1.3

22.5

2492

20798

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

22.5

1566

12202

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

22.5

317

1662

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.5

3227

27869

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

22.3

392

2222

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

22.1

358

1973

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

22.1

443

2615

N05BA01

ATC

diazepam; systemic, rectal

1.5

21.9

821

5694

K22

ICPC

Risk factor cardiovascular disease

1.9

21.9

351

1929

G44.2

ICD-10 Finland

Tension-type headache

1.5

21.9

692

4621

R02

ICPC

Shortness of breath/dyspnoea

1.5

21.8

721

4862

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.5

21.8

105

307

E000001

ATC

1.4

21.8

1160

8630

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

21.7

2480

20755

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

21.7

273

1371

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

80.3

21.7

O22.8

ICD-10 Finland

Other venous complications in pregnancy

80.3

21.7

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

220.6

21.6

W19

ICD-10 Finland

Unspecified fall

1.6

21.6

572

3654

PHL99

NOMESCO Finland

Ultrasound guided foam sclerotherapy of other vein

115.3

21.6

S76

ICPC

Skin infection other

2.0

21.5

299

1559

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

21.3

1098

8116

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

21.3

362

2030

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

21.3

1309

9984

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.2

21.1

195

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.9

21.1

332

1815

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

21.1

699

4721

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

21.1

614

4018

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

21.0

387

2225

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

21.0

238

1145

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

20.9

923

6622

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

20.9

804

5609

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

20.9

627

4134

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

20.7

411

2422

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.1

20.7

204

Z2221

NOMESCO Finland

Medical doctor

1.3

20.6

1640

13023

N06AA09

ATC

amitriptyline; systemic

1.6

20.4

613

4040

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

20.3

280

1457

A04

ICPC

Weakness/tiredness general

1.5

20.3

756

5235

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

20.3

407

2407

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

20.2

2586

21908

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

20.1

244

1209

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

20.1

200

910

L04AX01

ATC

azathioprine; systemic

2.0

20.0

251

1258

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

19.9

1172

8857

B01AE07

ATC

dabigatran etexilate; oral

2.0

19.9

262

1340

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

7.9

19.9

SPAT1234

SPAT

Support of social functional capacity

1.8

19.8

331

1846

WW500

NOMESCO Finland

Blood transfusion

2.0

19.8

248

1244

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

19.7

912

6601

A04AA02

ATC

granisetron; systemic, transdermal

1.8

19.6

364

2101

PHD79

NOMESCO Finland

200.5

19.6

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.3

19.5

182

801

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

19.5

650

4394

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

19.4

701

4819

R52.2

ICD-10 Finland

Other chronic pain

2.2

19.4

207

969

R05FB02

ATC

cough suppressants and expectorants

1.3

19.4

2406

20277

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

19.3

567

3717

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

19.3

1057

7890

ZZA00

NOMESCO Finland

Split skin graft

2.2

19.2

201

933

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

19.1

159

661

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

19.1

839

6008

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.9

19.0

289

1558

I87.8

ICD-10 Finland

Other specified disorders of veins

20.1

19.0

M01AX05

ATC

glucosamine; oral

1.4

19.0

1257

9684

C03DA01

ATC

spironolactone; oral

1.5

19.0

660

4501

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

18.9

284

1525

Z94.0

ICD-10 Finland

Kidney transplant status

3.6

18.9

237

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

18.8

155

643

Z2446

NOMESCO Finland

Social worker

1.7

18.8

372

2189

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

18.7

661

4524

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

18.7

355

2064

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

18.6

221

1084

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

18.6

499

3198

R03AC03

ATC

terbutaline; inhalant

1.5

18.6

786

5581

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

18.6

249

1284

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

18.5

3237

28377

B01AB01

ATC

heparin; parenteral

190.4

18.5

A11CC03

ATC

alfacalcidol; systemic

2.4

18.5

155

648

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

18.5

188

862

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

18.4

164

707

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

6.2

18.4

WZA90

NOMESCO Finland

Other doctors statement

1.4

18.4

1249

9654

SPAT1260

SPAT

Consultation of another employee

1.4

18.4

1035

7757

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

18.3

622

4216

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

18.3

1041

7813

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

18.3

456

2866

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

18.3

190

881

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

18.3

610

4121

R03BA02

ATC

budesonide; inhalant

1.4

18.3

983

7308

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

18.2

476

3030

I87.9

ICD-10 Finland

Disorder of vein, unspecified

11.8

18.2

M05BX04

ATC

denosumab; parenteral

1.8

18.2

319

1808

D07AC01

ATC

betamethasone; topical

1.3

18.2

2010

16656

L13

ICPC

Hip symptom/complaint

1.4

18.2

923

6788

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

18.2

669

4620

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

18.1

246

1275

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

18.1

436

2714

SPAT1172

SPAT

Guidance concerning hydration

2.3

18.1

161

694

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

18.0

711

4977

R55

ICD-10 Finland

Syncope and collapse

1.5

17.7

676

4700

A12AA04

ATC

calcium carbonate; oral

2.8

17.7

114

411

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

17.7

591

3992

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.0

17.7

242

1259

M09AX01

ATC

hyaluronic acid; parenteral

1.8

17.6

328

1893

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

17.6

126

484

5619

FHL

Other measure in this category

95.3

17.5

SPAT1153

SPAT

Removal of sutures

1.3

17.5

1943

16097

T82

ICPC

Obesity

2.2

17.4

181

839

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

17.4

3936

35414

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.4

17.3

144

598

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.2

17.3

183

856

N03AF02

ATC

oxcarbazepine; oral

2.2

17.3

185

869

N05AH04

ATC

quetiapine; oral

1.4

17.2

863

6331

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

17.2

1608

13015

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

17.2

219

1108

-50

ICPC

Medication/prescr/renewal

1.9

17.2

264

1432

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

17.1

238

1245

L03AA02

ATC

filgrastim; parenteral

2.2

17.1

171

778

128

Kela drug reimbursment

Cancers of female genital organs

2.7

17.0

115

427

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

17.0

401

2485

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

17.0

1458

11660

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

16.9

3179

27990

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

16.9

206

1023

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

16.9

104

365

N05CF01

ATC

zopiclone; oral

1.3

16.9

2068

17332

RT360

NOMESCO Finland

19.3

16.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

16.8

261

1422

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.0

16.8

203

1008

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

16.7

255

1381

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

16.7

169

777

M10.0

ICD-10 Finland

Idiopathic gout

2.0

16.7

206

1029

R03DC03

ATC

montelukast; oral

1.4

16.6

842

6184

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

16.6

2985

26142

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

16.5

349

2098

R04.0

ICD-10 Finland

Epistaxis

1.6

16.4

433

2761

SPAT1262

SPAT

Handing over of treatment supplies

1.3

16.4

1114

8596

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

20.1

16.4

R07.3

ICD-10 Finland

Other chest pain

1.5

16.4

545

3679

SPAT1310

SPAT

Counselling related to known health issue

1.3

16.2

1854

15386

N06AB04

ATC

citalopram; systemic

1.3

16.2

1244

9780

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

16.2

1489

12012

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

16.2

449

2900

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

16.2

299

1727

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

16.2

1177

9180

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

16.1

167

774

N06AX16

ATC

venlafaxine; oral

1.5

16.1

674

4772

L04AA01

ATC

[U] ciclosporin; systemic

2.9

16.1

100

353

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

16.1

146

637

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.5

16.1

127

516

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

16.1

391

2444

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

16.0

405

2556

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

16.0

320

1893

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

16.0

269

1505

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

15.9

428

2743

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

15.9

244

1322

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

15.9

2271

19357

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

15.8

540

3664

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.5

15.8

209

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

15.8

299

1740

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

15.8

431

2776

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

15.7

127

521

N02AC04

ATC

dextropropoxyphene; oral

1.8

15.7

263

1469

S06.0

ICD-10 Finland

Concussion

1.5

15.6

568

3908

WX882

NOMESCO Finland

High dependency care

2.2

15.6

163

757

28920

ICD-8 Finland

Other disease of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis

+∞

15.6

C07AB07

ATC

bisoprolol; oral

1.2

15.6

3118

27554

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1036

1587

7.31

307.65

2.3

2.1

97.3

89.4

19.97

910

1490

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3702

13458

4.14

307.65

2.3

1.7

mg/l

1.9

1.2

16.97

2961

10354

(3032080) INR in Blood by Coagulation assay

4644

28270

2.44

307.65

15.5

8.9

inr

1.4

1.3

15.89

1276

7830

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

837

1481

6.17

307.65

2.7

2.4

197.3

197.4

0.00

759

1411

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

663

695

10.27

307.65

1.3

1.2

u/ml

3.7

4.3

0.44

281

304

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

534

469

12.09

307.65

1.2

1.1

94.3

96.1

0.55

474

441

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

748

612

13.32

307.65

1.1

118.8

117.6

0.29

623

554

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

926

2331

4.34

307.65

3.6

2.8

u/ml

0.4

0.3

1.34

629

1287

(4306422)

788

646

13.36

307.65

1.2

—

(4268621)

428

479

9.36

307.65

2.4

2.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

681

699

10.52

307.65

1.3

1.2

u/ml

3.8

3.6

0.07

213

222

(3022217) INR in Platelet poor plasma by Coagulation assay

2194

9429

2.80

307.65

37.4

25.9

inr

1.7

1.4

8.34

232

1338

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

754

645

12.75

307.65

1.1

—

(3036489) Thrombin time

1114

2032

6.17

307.65

2.2

2.0

21.4

0.04

841

1820

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

256

179

14.72

284.69

1.1

1.0

93.1

97.1

0.67

187

142

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

284

254

11.54

272.00

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

277

252

11.33

262.26

1.2

1.1

ratio

1.1

0.56

(3023368) Bacteria identified in Blood by Culture

3207

19147

2.09

215.68

5.4

4.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

595

1651

3.80

184.24

3.2

2.4

g/l

3.6

3.7

0.35

563

1561

(3033658) Prothrombin time (PT) actual/Normal

2800

17034

1.97

169.20

5.0

3.8

84.9

88.6

9.14

2687

16617

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4789

35377

1.83

151.58

8.1

6.0

umol/l

10.9

11.6

4.18

4579

33490

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

184

218

8.61

143.27

1.2

1.1

u/ml

9.4

21.3

0.35

(3001604) Monocytes [#/volume] in Blood

4468

32754

1.78

140.69

7.3

5.6

e9/l

0.6

0.22

3854

27940

(3006315) Basophils [#/volume] in Blood

4485

32953

1.78

139.76

7.3

5.6

e9/l

0.0

1.28

3867

28127

(3019198) Lymphocytes [#/volume] in Blood

4557

33671

1.78

138.94

7.4

5.6

e9/l

1.8

1.9

2.91

3993

29281

(3013650) Neutrophils [#/volume] in Blood by Automated count

5011

38129

1.78

137.37

12.4

8.8

e9/l

4.2

0.46

4437

33022

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1882

10604

2.00

137.14

3.0

2.0

30.8

29.8

7.53

1828

10284

(3013115) Eosinophils [#/volume] in Blood

4581

33986

1.77

136.86

7.7

5.8

e9/l

0.2

1.21

4006

29477

(3006504) Eosinophils/100 leukocytes in Blood

4217

30720

1.75

132.71

7.6

5.8

2.8

2.9

1.29

3934

28371

(3019069) Monocytes/100 leukocytes in Blood

4234

30901

1.75

132.17

8.0

6.1

8.7

0.30

3959

28657

(3013826) Glucose [Moles/volume] in Serum or Plasma

5184

40165

1.76

130.03

6.1

4.6

mmol/l

6.7

6.8

1.29

4945

37550

(3002030) Lymphocytes/100 leukocytes in Blood

4298

31642

1.74

128.79

7.8

6.0

26.3

27.1

4.69

3995

29171

(3022096) Basophils/100 leukocytes in Blood

4101

29815

1.74

128.42

7.7

5.9

0.6

0.7

2.22

3824

27559

(42870588) Differential panel, method unspecified - Blood

3286

22453

1.76

128.19

7.2

5.7

—

(3018010) Neutrophils/100 leukocytes in Blood

4233

31191

1.72

125.00

7.4

5.7

58.6

57.9

3.26

3958

28904

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4226

31252

1.71

122.04

8.0

5.9

mmol/l

1.2

0.06

3865

28140

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4585

34670

1.71

121.92

9.4

6.6

mmol/l

1.2

0.21

3931

29138

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

142

152

9.49

119.57

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

146

164

9.04

118.52

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4063

29987

1.69

116.00

6.7

4.6

g/l

34.1

35.2

25.68

3780

27665

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1903

11339

1.88

114.60

2.1

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1623

9308

1.92

109.29

2.4

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3025

20912

1.70

108.23

3.2

3.0

ng/l

1592.9

1653.6

0.20

2623

17990

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6236

52187

1.77

106.65

11.0

7.3

u/l

80.2

79.1

0.93

5946

48956

(3007853) Bacteria identified in Skin by Aerobe culture

1366

7572

1.96

100.98

2.1

1.7

—

(3034426) Prothrombin time (PT)

132

176

7.60

93.10

1.2

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5417

44406

1.62

91.90

6.4

4.6

e6/l

1276.5

1997.3

0.72

669

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1647

9975

1.81

91.47

2.9

2.5

g/l

2.3

0.64

1535

9182

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1561

9331

1.83

90.40

3.0

2.5

21.6

22.1

0.64

1327

7870

(3044640) Blood type and Crossmatch panel - Blood

2982

21307

1.62

89.31

3.0

2.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1780

11153

1.76

87.57

4.0

3.2

mmol/l

0.8

3.06

1662

10359

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3585

26873

1.58

87.16

4.5

3.8

ng/l

42.6

80.8

1.37

2721

19198

(3037467) Urinalysis macro (dipstick) panel - Urine

5551

46102

1.61

86.10

6.1

4.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2959

21278

1.60

85.31

3.2

2.5

u/l

53.8

58.4

7.20

2760

19606

(3022948) Iron [Moles/volume] in Serum or Plasma

1722

10804

1.75

83.85

3.0

2.5

umol/l

12.0

12.7

3.67

1607

9916

(3002582) Erythrocytes [#/volume] in Urine

2912

20985

1.59

82.50

4.4

3.2

e6/l

119.2

87.6

0.46

2327

16098

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4009

31116

1.55

81.80

5.0

4.0

—

(3018095) Leukocytes [#/volume] in Urine

3256

24216

1.56

79.72

5.0

3.7

e6/l

97.3

108.9

0.38

2453

17317

(3030467) Casts [#/volume] in Urine by Automated count

2700

19236

1.60

79.61

4.2

3.2

e6/l

0.4

0.03

2123

14509

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1467

8907

1.78

79.58

7.8

5.5

mmol/l

1.0

0.33

1370

8221

(3026008) Bacteria identified in Urine by Culture

2897

21122

1.57

76.61

4.1

3.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1092

6168

1.89

74.52

8.8

7.0

mmol/l

11.0

10.4

1.44

1022

5839

(3018418) pH of Serum or Plasma

2816

20513

1.56

74.17

5.6

3.9

7.4

0.46

550

3831

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2313

16126

1.60

73.49

2.9

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1307

7844

1.79

73.17

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1304

7852

1.78

72.09

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

2583

18597

1.56

70.92

4.2

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

936

5103

1.94

70.91

1.9

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1316

7990

1.77

70.59

4.4

4.1

u/l

242.5

245.2

0.30

1235

7504

(3000850) Epithelial cells [#/volume] in Urine

2109

14590

1.60

68.35

3.5

2.6

e6/l

5.2

0.07

1883

12725

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2857

21166

1.53

68.30

2.5

2.1

u/l

193.2

226.3

1.22

2702

19759

(3003396) Base excess in Arterial blood by calculation

1327

8148

1.75

68.22

7.1

mmol/l

1.1

0.13

1059

6319

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2433

17443

1.56

67.33

2.6

2.2

mg/l

3.3

3.0

5.42

2080

14788

(3015377) Calcium [Moles/volume] in Serum or Plasma

3076

23267

1.51

66.08

4.4

3.4

mmol/l

2.3

2.4

4.14

2702

20055

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1321

8169

1.73

66.03

7.2

7.0

kpa

5.1

0.16

1261

7781

(3027801) Oxygen [Partial pressure] in Arterial blood

1320

8165

1.73

65.90

7.2

7.0

kpa

11.9

12.2

1.26

1256

7772

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1990

13700

1.59

65.35

4.6

3.9

ng/l

280.4

515.0

1.81

1621

11100

(3016502) Oxygen saturation in Arterial blood

1196

7308

1.74

62.06

7.3

7.4

95.8

95.5

1.00

1145

7018

(40758558) Short blood count panel - Blood

2323

16765

1.53

61.21

9.1

6.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5707

49284

1.50

60.71

5.4

4.0

mm/h

15.3

13.0

20.15

5296

45319

(3026493) Urate [Moles/volume] in Serum or Plasma

2462

18067

1.51

59.68

3.6

2.6

umol/l

5028.5

5253.1

0.09

2125

15462

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1739

11893

1.58

57.70

3.5

2.8

e6/l

1.4

0.01

1040

6881

(44806071)

11.42

56.84

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3447

27232

1.45

56.84

3.4

2.8

ug/l

160.1

144.8

1.44

3160

24899

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

7.18

56.61

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1084

6646

1.72

55.10

4.6

3.6

kpa

5.9

5.8

0.90

1050

6450

(3002032) Base excess in Venous blood by calculation

1081

6632

1.72

54.79

4.6

3.6

mmol/l

2.0

1.9

0.21

901

5355

(3026782) Osmolality of Urine

1936

13747

1.53

53.77

3.7

2.8

mosm/kgh2o

542.0

549.1

0.75

1703

11671

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1084

6703

1.71

53.29

7.9

g/l

120.6

120.9

0.20

1048

6466

(3012544) pH of Venous blood

1103

6897

1.69

51.93

4.6

3.6

7.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1609

11048

1.57

51.74

3.7

2.9

e6/l

2.9

2.5

0.76

916

6071

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7201

66149

1.64

51.27

25.8

14.8

mg/l

25.5

25.2

0.36

6494

52842

(3014576) Chloride [Moles/volume] in Serum or Plasma

1346

8906

1.61

50.59

7.5

6.8

mmol/l

104.8

104.4

2.78

1305

8724

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

732

4095

1.86

50.49

4.2

3.4

mmol/l

1.7

1.8

0.41

548

3035

(3009343) pH of Capillary blood

753

4257

1.84

50.22

4.3

3.5

7.4

0.02

105

527

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

492

2405

2.11

50.01

2.4

2.3

ug/l

310.9

629.3

2.65

467

2269

(3020630) Protein [Mass/volume] in Serum or Plasma

965

5902

1.72

49.13

3.7

2.5

g/l

65.3

66.3

3.14

862

5303

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2740

21158

1.44

49.01

4.1

3.1

u/l

31.8

35.5

2.40

2593

19941

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

758

4326

1.83

48.98

4.3

3.5

kpa

5.2

5.1

0.13

699

3969

(3014111) Lactate [Moles/volume] in Serum or Plasma

992

6135

1.70

48.44

6.6

6.7

mmol/l

1.4

0.56

961

5897

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

723

4104

1.83

47.49

1.7

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

3937

32536

1.40

47.25

4.9

3.7

estimate

0.0

1.08

776

5802

(3019060) Gas panel - Arterial blood

809

4778

1.77

46.50

5.1

4.8

—

(3044009) aPTT.lupus sensitive (LA screen)

12.17

46.14

1.2

—

(3000991) Gas panel - Venous blood

942

5818

1.70

46.10

8.3

7.9

—

(3019174) dRVVT (LA screen)

11.85

45.40

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

295

1221

2.47

44.51

5.7

5.2

iu/ml

12062.9

2425.9

0.39

180

(3027945) Reticulocytes/100 erythrocytes in Blood

1214

8065

1.59

44.35

3.0

2.4

1.8

1.04

1058

7068

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

546

2892

1.95

44.33

2.3

1.9

ug/l

2.5

2.3

0.13

483

2517

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

862

5258

1.71

44.07

4.7

3.6

ng/l

107.1

93.2

3.05

760

4465

(3021601) Nitrite [Presence] in Urine by Test strip

3921

32624

1.38

43.92

6.6

5.0

estimate

0.0

0.80

792

5871

(3009261) Glucose [Presence] in Urine by Test strip

3959

33006

1.38

43.73

5.0

3.8

estimate

0.0

0.02

760

5722

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3355

27279

1.38

42.95

2.6

2.2

nmol/l

76.1

78.2

4.38

3010

24192

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

971

6175

1.65

42.28

2.3

2.1

g/l

0.2

0.79

895

5750

(3024354) Oxygen [Partial pressure] in Venous blood

880

5456

1.68

42.26

3.5

3.0

kpa

4.6

4.5

0.55

845

5270

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

713

4189

1.77

41.55

1.8

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1214

8209

1.56

40.79

1.4

1.3

titre

466.1

512.2

0.41

276

1734

(3021589) Normoblasts [#/volume] in Blood

3527

29105

1.37

40.34

13.3

9.5

e9/l

0.0

0.13

2894

23681

(3019309) Folate [Moles/volume] in Red Blood Cells

1864

13815

1.45

40.00

1.9

1.8

nmol/l

1113.0

1153.8

1.05

1429

10323

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3492

28933

1.36

38.21

2.2

2.0

pmol/l

93.8

94.7

0.55

1973

14996

(3022313) Gas panel - Capillary blood

550

3067

1.85

38.04

4.4

3.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

514

2827

1.87

37.12

1.8

1.5

u/ml

13.4

17.9

0.40

(3004588) Protein electrophoresis panel - Serum or Plasma

780

4843

1.67

37.04

3.3

2.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

267

1153

2.36

36.69

3.5

1.5

1.4

0.20

207

869

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

368

1823

2.07

36.01

1.6

1.3

iu/ml

16.5

15.9

0.02

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

566

3254

1.79

35.37

4.7

3.8

mmol/l

24.1

0.05

518

2902

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

480

2624

1.88

35.31

4.7

3.7

mmol/l

24.8

0.09

443

2388

(3023520) Reticulocytes [#/volume] in Blood

921

6030

1.59

35.25

3.1

2.4

e9/l

70.1

69.1

0.31

681

4587

(3008152) Bicarbonate [Moles/volume] in Arterial blood

731

4528

1.67

34.96

7.5

7.0

mmol/l

24.7

24.5

0.66

686

4220

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

951

6285

1.58

34.96

3.0

2.9

ng/l

218.7

219.1

0.01

864

5726

(3005719) IgG [Mass/volume] in Serum or Plasma

740

4613

1.66

34.52

3.6

2.6

g/l

10.4

10.5

0.24

676

4195

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1103

7560

1.53

34.41

4.4

4.0

ug/l

45.6

24.9

0.78

903

6183

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1740

13040

1.42

34.38

3.9

3.1

mmol/l

2.5

2.09

1516

11284

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

400

2079

1.97

34.22

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2111

16395

1.38

33.76

1.7

1.5

nmol/l

19.0

20.3

3.83

1832

13951

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

939

6269

1.56

32.91

3.0

2.5

u/l

69.9

47.4

0.39

818

5358

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4803

42230

1.32

32.89

3.9

3.0

u/l

56.2

50.3

3.36

4465

38910

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

705

4401

1.66

32.65

8.5

8.8

0.7

0.48

698

4368

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1103

7663

1.51

32.12

3.1

2.5

umol/l

8.4

8.6

0.08

967

6638

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

611

3692

1.71

31.99

8.4

9.0

mmol/l

24.3

0.01

573

3439

(3034860) Kappa light chains.free [Mass/volume] in Serum

421

2281

1.89

31.81

4.8

3.2

mg/l

58.9

80.6

0.41

340

1873

(3000494) Fungus identified in Specimen by Culture

1082

7507

1.51

31.68

1.6

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

875

5797

1.57

31.66

2.4

2.2

nmol/l

363.3

379.8

1.47

810

5290

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

219

931

2.39

31.22

2.7

2.5

u/ml

935.1

1412.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2011

15661

1.37

31.20

4.6

3.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

701

4420

1.64

31.16

8.5

8.7

1.5

1.4

1.35

694

4390

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

419

2283

1.88

31.11

4.8

3.2

mg/l

42.1

49.8

0.50

336

1875

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

424

2333

1.86

30.52

3.1

2.3

g/l

1.5

0.9

1.99

355

1982

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

408

2223

1.88

30.29

4.6

3.1

ratio

22.7

3.2

0.63

168

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

320

1607

2.03

30.17

1.8

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

211

896

2.39

30.16

6.7

6.5

mg/l

11.9

0.11

188

824

(3017181) Myelocytes/100 leukocytes in Blood

857

5715

1.56

30.05

4.9

3.9

0.9

0.01

343

1638

(3019550) Sodium [Moles/volume] in Serum or Plasma

7305

68880

1.48

29.86

27.6

17.4

mmol/l

139.6

0.02

7188

67084

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

481

2774

1.78

29.67

2.9

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

481

2776

1.78

29.60

2.9

2.2

g/l

7.4

0.19

356

2038

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

623

3861

1.66

29.60

9.5

9.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

454

2577

1.81

29.55

3.0

2.2

g/l

3.1

0.37

346

2003

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

361

1909

1.93

29.35

1.9

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

479

2772

1.77

29.20

2.9

2.2

g/l

3.8

0.05

339

1956

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

351

1845

1.94

29.05

1.9

1.6

g/l

1.2

0.21

334

1740

(3008757) Leukocyte morphology finding [Identifier] in Blood

183

741

2.50

29.02

4.2

3.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

902

6129

1.53

29.00

1.7

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

498

2924

1.75

28.87

2.4

1.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

340

1779

1.95

28.53

1.9

1.6

g/l

0.2

0.51

320

1677

(3021440) Promyelocytes/100 leukocytes in Blood

812

5421

1.55

28.26

4.9

3.9

0.1

0.2

1.13

321

1514

(3023103) Potassium [Moles/volume] in Serum or Plasma

7309

69065

1.46

28.14

27.9

17.5

mmol/l

4.0

13.83

7185

67137

(3023420) DNA double strand Ab [Units/volume] in Serum

162

629

2.61

28.04

1.5

iu/ml

47.5

21.6

0.86

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

307

1561

2.00

27.97

1.9

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

778

5178

1.55

27.42

4.8

3.7

0.8

0.6

1.35

247

1172

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

448

2601

1.76

26.99

2.9

2.2

g/l

10.1

10.2

0.08

367

2171

(3021788) Differential panel - Synovial fluid

242

1150

2.14

26.46

1.6

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

299

1538

1.98

26.37

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

299

1538

1.98

26.37

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

303

1583

1.95

25.55

1.8

1.6

e6/l

10678.7

13830.9

0.86

204

1130

(3010421) pH of Blood

329

1772

1.89

25.32

5.3

4.2

7.4

0.14

280

1502

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

254

1260

2.05

24.81

2.0

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

389

2233

1.78

24.37

1.6

titre

155.0

339.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

668

4426

1.55

23.93

3.7

3.3

g/l

127.1

128.4

0.83

660

4329

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

362

2050

1.80

23.74

2.5

2.1

g/l

0.0

0.05

328

1858

(46235355) HIV 1 and 2 tests - Meaningful Use set

1146

8464

1.41

23.67

1.8

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

375

2148

1.78

23.67

2.5

2.1

g/l

36.8

37.6

1.55

318

1824

(3044941) Cell count panel - Synovial fluid

210

990

2.15

23.48

1.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

444

2680

1.69

23.26

2.1

1.8

—

(3025159) Blasts/100 leukocytes in Blood

741

5079

1.50

22.64

4.9

3.9

0.1

0.2

0.55

275

1268

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

521

3300

1.62

22.61

1.8

1.6

g/l

1.6

0.08

462

2794

(3027315) Oxygen [Partial pressure] in Blood

289

1551

1.89

22.51

5.3

4.3

kpa

8.6

8.5

0.28

284

1512

(3037121) Protein [Mass/volume] in Urine

390

2301

1.73

22.20

4.0

2.9

g/l

0.4

0.3

0.60

174

939

(40760892) CBC W Ordered Manual Differential panel - Blood

1754

13998

1.32

21.89

6.0

4.4

—

(3012501) Base excess in Blood by calculation

285

1537

1.88

21.88

5.3

4.2

mmol/l

2.7

2.6

0.29

206

1026

(3013290) Carbon dioxide [Partial pressure] in Blood

285

1538

1.88

21.84

5.3

4.2

kpa

5.0

0.02

280

1500

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

521

3330

1.60

21.77

2.8

2.6

0.7

1.16

503

3188

(3028026) IgM [Mass/volume] in Serum or Plasma

556

3610

1.58

21.73

2.3

1.8

g/l

1.3

1.4

0.17

496

3257

(40760888) Immunoglobulin light chains.free panel - Serum

309

1714

1.83

21.71

5.4

3.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

413

2491

1.69

21.69

4.6

3.9

mmol/l

1.4

0.39

404

2451

(3019225) pH of Specimen

952

6908

1.43

21.61

6.5

4.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

989

7231

1.42

21.51

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

967

7051

1.42

21.35

4.4

3.4

—

(40761535) Cells panel - Urine sediment

818

5801

1.45

21.00

4.5

3.5

—

(1616796) Gas panel - Central venous blood

279

1517

1.87

20.89

4.5

3.6

—

(40767503) Oxygen content in Capillary blood by calculation

272

1467

1.88

20.89

2.9

2.4

16.6

16.1

1.00

138

769

(3027273) Bicarbonate [Moles/volume] in Venous blood

548

3588

1.56

20.64

4.6

3.3

mmol/l

25.2

0.22

538

3486

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

332

1911

1.77

20.63

2.6

2.1

g/l

0.0

0.50

299

1723

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

229

1171

1.98

20.61

1.9

1.7

—

(3013512) EKG study

2424

20316

1.27

20.55

4.5

4.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

890

6452

1.42

20.25

2.5

2.4

ug/l

6.7

7.4

0.22

748

5551

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

325

1877

1.76

19.97

2.6

2.2

g/l

0.0

0.00

298

1717

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

286

1592

1.82

19.89

1.5

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

309

1770

1.77

19.53

1.6

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

272

1503

1.84

19.37

3.2

2.7

kpa

8.2

7.9

2.24

252

1376

(3025941) Bacteria identified in Stool by Culture

533

3522

1.55

19.27

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

335

1972

1.73

19.25

1.4

ug/g

271.5

274.9

0.10

192

1178

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

158

722

2.21

19.17

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1289

10012

1.34

19.14

1.3

1.2

u/ml

13.0

13.2

0.02

454

3810

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6615

62355

1.29

19.10

22.0

14.0

ml/min/173m2

76.7

77.8

3.54

5804

51525

(40768804) Tissue Pathology biopsy report

3097

26871

1.24

19.07

2.3

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

408

2538

1.64

19.04

3.9

3.3

u/ml

3229.7

593.0

0.53

341

2157

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

291

1653

1.79

18.93

4.0

2.6

mg/l

1.8

1.6

4.27

267

1490

(40768797) Stomach Pathology biopsy report

1182

9081

1.35

18.85

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

320

1872

1.74

18.81

1.6

iu/ml

0.6

8.2

1.13

412

(3037756) Immunofixation for Serum or Plasma

264

1464

1.83

18.60

2.2

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

352

2124

1.69

18.48

4.0

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2118

17652

1.27

18.41

5.5

4.1

estimate

0.0

0.02

738

5623

(3007164) IgA [Mass/volume] in Serum or Plasma

1439

11421

1.31

18.29

1.8

1.4

g/l

2.5

0.07

881

6735

(3028271) Lactate [Moles/volume] in Capillary blood

208

1074

1.96

18.25

2.2

1.9

mmol/l

1.8

1.7

0.57

202

1052

(3010375) cycloSPORINE [Mass/volume] in Blood

255

3.04

18.09

32.4

25.0

ug/l

104.0

109.4

0.37

210

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4123

37006

1.23

18.04

3.0

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

155

721

2.17

18.02

4.2

3.5

62.0

59.1

0.83

108

446

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

469

3062

1.56

17.88

6.0

5.2

1.6

0.12

436

2870

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

123

4.00

17.57

1.4

1.3

mg/l

68.8

133.8

0.30

(3020891) Body temperature

442

2859

1.58

17.55

4.9

4.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

261

1472

1.80

17.42

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

462

3026

1.56

17.37

5.9

5.3

0.9

0.91

430

2841

(3022806) Fractional oxyhemoglobin in Capillary blood

176

872

2.04

17.36

2.1

1.8

89.7

89.6

0.08

170

863

(3023183) Ammonium ion [Moles/volume] in Plasma

232

1265

1.86

17.28

3.1

2.1

umol/l

31.6

32.9

0.36

187

1061

(3048689) Calprotectin [Mass/mass] in Stool

950

7153

1.37

17.15

2.5

2.2

ug/g

172.9

147.7

0.89

762

5609

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

792

5789

1.41

17.09

5.4

3.7

mmol/l

1.2

0.04

699

5022

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2894

25164

1.23

16.86

5.4

4.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1336

10604

1.31

16.84

1.4

1.3

iu/ml

51.8

36.5

0.46

391

3292

(3015235) Bicarbonate [Moles/volume] in Capillary blood

302

1796

1.71

16.76

3.2

3.0

mmol/l

24.8

24.9

0.24

268

1554

(3043409) Potassium [Moles/volume] in Arterial blood

347

2141

1.65

16.75

4.7

4.1

mmol/l

3.9

0.02

320

2012

(3022145) Colonoscopy Study observation

978

7428

1.36

16.69

1.4

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

130

584

2.25

16.50

2.4

1.9

g/24h

1.2

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

272

1584

1.74

16.29

2.3

2.2

g/l

128.7

128.5

0.04

204

1137

(40761511) CBC panel - Blood by Automated count

7146

68369

1.31

16.28

22.7

14.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

192

1006

1.93

16.18

1.3

1.2

u/ml

276.6

279.1

0.04

129

622

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

202

1081

1.89

15.98

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

383

2452

1.59

15.91

3.0

2.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

252

1454

1.76

15.60

3.3

u/ml

3422.0

607.3

0.93

229

1329

(4035726)

819

6110

1.38

15.60

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

252

1469

1.74

15.06

1.5

1.4

—

(3021901) Oxygen saturation in Capillary blood

226

1280

1.79

14.93

3.2

2.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

260

1542

1.71

14.62

1.3

u/ml

4.2

3.4

0.21

153

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

175

924

1.91

14.46

1.7

1.5

—

(44790047)

147

735

2.02

14.23

1.7

1.4

—

(44790048)

147

735

2.02

14.23

1.7

1.4

—

(44790049)

147

735

2.02

14.23

1.7

1.4

—

(44806118)

147

735

2.02

14.23

1.7

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7304

70318

1.30

14.18

28.2

17.4

umol/l

84.3

79.7

14.94

7304

70284

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

731

5437

1.38

14.16

3.7

2.7

ml/min/173m2

61.8

64.1

0.82

321

2195

(3024891) Influenza virus A+B Ag [Presence] in Specimen

268

1619

1.68

14.08

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

260

1563

1.68

13.92

1.3

u/ml

10.8

5.4

0.61

251

(3039000) Anion gap in Blood

268

1625

1.67

13.89

7.4

7.2

mmol/l

11.4

11.3

0.10

238

1456

(3018572) Chloride [Moles/volume] in Blood

268

1626

1.67

13.86

7.4

7.2

mmol/l

105.2

0.01

238

1457

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

223

2.88

13.84

3.2

2.5

—

(3047181) Lactate [Moles/volume] in Blood

349

2267

1.56

13.65

6.8

6.3

mmol/l

1.3

0.30

311

2006

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

294

1835

1.62

13.61

1.9

1.7

—

(3024928) Oxygen saturation in Venous blood

242

1436

1.71

13.61

2.7

3.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

582

2.11

13.42

2.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

582

2.11

13.42

2.0

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

582

2.11

13.42

2.0

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

220

1277

1.74

13.40

1.3

1.2

u/ml

2.0

4.0

0.62

100

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

139

702

2.00

13.12

2.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

160

848

1.90

13.12

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

616

4510

1.39

13.11

3.9

3.0

e9/l

4.2

0.02

431

3390

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

837

1.90

12.98

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

157

830

1.91

12.97

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5339

49892

1.19

12.97

4.2

3.9

pmol/l

15.0

14.9

2.20

4852

44968

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

1118

1.77

12.70

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

657

2.01

12.62

2.1

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

270

1682

1.63

12.62

1.3

u/ml

60.9

45.8

—

(3014271) Vancomycin [Susceptibility]

385

2.33

12.46

3.2

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6346

60349

1.21

12.37

5.2

4.7

mu/l

1.9

2.3

3.14

5797

54736

(3005988) Vibrio sp identified in Specimen by Organism specific culture

156

837

1.88

12.35

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7290

70376

1.28

12.32

15.5

10.4

u/l

26.2

0.01

7092

67586

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

427

2.24

12.17

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

155

835

1.87

12.12

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

155

835

1.87

12.12

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

1039

1.78

12.07

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

1186

1.72

11.86

1.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

549

4011

1.39

11.83

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

427

2.22

11.75

1.2

—

(3049717) Cytology report of Urine Cyto stain

407

2823

1.46

11.69

2.6

2.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

428

2.21

11.69

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1698

14424

1.22

11.57

5.5

4.2

kg/l

1.0

0.13

275

2205

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

163

3.02

11.56

9.2

5.3

67.3

71.2

0.58

124

(3045788) Cell count panel - Pleural fluid

136

715

1.92

11.48

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

432

2.19

11.43

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

432

2.19

11.43

1.2

—

(3012516) Albumin [Mass/volume] in Urine

2388

20975

1.19

11.42

3.9

3.2

mg/l

630.8

373.5

1.47

1589

13228

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

219

2.71

11.41

1.5

1.9

u/ml

39166.2

60950.0

0.15

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

131

682

1.94

11.39

3.3

3.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

433

2.18

11.37

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2000

17294

1.21

11.33

4.7

3.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

439

3111

1.43

11.26

5.1

3.7

u/ml

65.8

65.6

0.01

420

2979

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

449

2.15

11.19

1.3

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

145

789

1.85

11.03

1.7

1.5

61.3

60.0

0.15

495

(3009508) Creatinine [Moles/volume] in Urine

2468

21807

1.19

10.93

3.7

3.1

mmol/l

7.3

7.5

1.11

2048

18063

(3044889) 12 lead EKG panel

5086

47637

1.17

10.92

4.3

3.9

—

(40768446) Kidney Pathology biopsy report

214

2.67

10.81

1.7

1.6

—

(3022621) pH of Urine by Test strip

609

4596

1.35

10.73

3.3

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

172

998

1.74

10.58

1.6

1.4

u/ml

113.4

119.8

0.36

209

(40761536) Microorganisms panel - Urine sediment

710

5492

1.32

10.57

5.3

3.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

264

2.47

10.52

2.2

2.0

102.7

97.8

0.48

248

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

162

926

1.76

10.50

1.5

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

131

704

1.87

10.39

2.8

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

340

2.28

10.35

2.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

340

2.28

10.35

2.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

340

2.28

10.35

2.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

340

2.28

10.35

2.3

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2495

22147

1.18

10.34

4.5

3.9

mg/mmol

12.5

9.1

2.61

1630

13991

(3014765) Yersinia sp identified in Stool by Organism specific culture

281

1855

1.53

10.31

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1530

13013

1.22

10.15

1.3

1.2

u/ml

1.2

1.9

2.69

400

3401

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

104

522

2.00

10.09

2.9

1.8

mg/l

3.7

4.3

0.94

497

(42529406) Shigella sp [Presence] in Stool by Culture

281

1864

1.53

10.09

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

277

1833

1.53

10.06

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

137

755

1.83

10.05

1.7

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

340

2348

1.47

10.03

1.3

1.2

u/ml

1.4

0.8

0.48

217

(4010399)

628

4822

1.33

9.85

1.5

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

175

1048

1.68

9.64

1.4

1.5

g/l

32.3

32.0

0.12

152

922

(40768443) Skin Pathology biopsy report

405

2912

1.41

9.62

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

500

1.99

9.47

1.2

u/ml

32.8

76.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

235

1521

1.56

9.46

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

499

3729

1.36

9.39

3.9

2.7

e6/l

0.3

0.12

484

3644

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1747

15146

1.19

9.37

1.7

pmol/l

30662439.0

29993994.1

0.01

1435

12426

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

504

1.98

9.27

1.2

u/ml

13.4

31.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.81

9.21

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

263

2.37

9.18

2.5

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

263

2.37

9.18

2.5

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

264

2.36

9.11

2.6

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

244

1610

1.53

9.02

1.2

titre

69.2

194.4

1.75

125

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

461

2.01

9.02

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

188

1168

1.62

9.01

1.7

1.5

—

(36660697) Celiac disease serology panel - Serum

603

4664

1.32

8.99

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

471

1.99

8.86

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

513

1.94

8.83

1.3

1.2

u/ml

25.8

47.5

—

(3034770) Mitochondria Ab [Titer] in Serum

242

1607

1.52

8.70

1.2

titre

1514.3

882.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

372

2684

1.40

8.69

1.9

u/l

37.6

38.9

0.54

322

2337

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

516

1.93

8.69

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

281

1925

1.48

8.69

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

472

3546

1.35

8.60

1.4

1.3

u/ml

220.0

242.2

0.22

432

3262

(3036782) Glucose [Moles/volume] in Pleural fluid

124

699

1.79

8.52

1.2

1.4

mmol/l

6.2

6.4

0.28

116

633

(3017704) Immunofixation for Urine

366

2.09

8.33

2.1

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

155

937

1.67

8.30

1.4

1.5

e6/l

2157.4

2366.2

0.10

107

669

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

844

6899

1.25

8.09

2.0

1.7

1.5

0.62

714

5975

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

150

906

1.67

8.08

2.3

2.0

mg/l

26.7

25.5

0.07

227

(3045414) Leukocytes [Presence] in Urine

406

3016

1.36

7.98

2.1

1.9

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

201

1308

1.55

7.96

1.3

1.2

titre

160.0

192.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

3.43

7.92

1.2

1.4

68.3

79.4

0.83

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

484

1.91

7.90

1.2

1.1

titre

191.0

134.1

0.41

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

548

1.85

7.89

1.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

156

961

1.64

7.79

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

175

1109

1.59

7.79

1.3

1.2

u/l

55.5

36.2

0.55

157

956

(21494434) Karyotype in Bone marrow

105

580

1.82

7.75

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

949

1.63

7.69

1.6

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

351

2.06

7.67

9.9

11.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6408

61723

1.16

7.64

6.6

6.0

mmol/mol

40.7

40.3

2.62

5917

56632

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

312

2.12

7.62

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

312

2.12

7.62

1.3

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

141

853

1.66

7.57

1.3

1.5

e6/l

66549.4

56337.5

0.16

496

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

527

1.85

7.56

1.9

1.6

—

(3045142) Bone marrow Pathology biopsy report

126

741

1.71

7.52

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

543

1.83

7.49

2.5

2.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.23

7.46

1.1

—

(4015189)

166

2.54

7.31

3.3

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

148

916

1.63

7.29

5.0

4.8

umol/l

337.0

358.4

0.91

122

779

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.60

7.28

2.2

2.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

305

2.11

7.26

2.4

2.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

238

1638

1.47

7.26

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

185

1209

1.54

7.23

4.7

3.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

340

2.04

7.17

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

340

2.04

7.17

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

104

588

1.78

7.15

1.7

1.5

29.8

29.7

0.01

360

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.12

7.11

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

227

1555

1.47

7.10

1.4

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

151

2.59

7.09

1.8

1.5

ug/l

0.4

0.12

(3000492) Spirometry study

723

5899

1.25

7.05

1.6

1.5

—

(3000330) Specific gravity of Urine by Test strip

482

3743

1.31

7.02

4.8

3.7

—

(3008898) HLA-B27 [Presence]

256

1800

1.44

6.99

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1064

9049

1.20

6.90

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

122

730

1.68

6.87

1.3

u/ml

82.8

57.2

—

(3002256) Pathology report gross observation

1038

8813

1.20

6.85

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.45

6.70

1.3

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

263

2.14

6.63

2.1

2.2

umol/l

48.6

56.5

0.92

208

(3042631) Mycobacterium sp identified in Specimen

152

971

1.58

6.61

2.7

2.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.57

6.58

2.2

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

224

3176

0.70

6.57

1.4

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

130

802

1.63

6.53

3.2

3.4

nmol/l

10.9

13.7

0.13

125

785

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.81

6.52

1.0

—

(3044927) Protein electrophoresis panel - Urine

116

697

1.67

6.46

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

630

1.71

6.43

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

181

1210

1.51

6.42

1.3

u/ml

40.1

45.1

0.16

125

(3023383) Lactate [Moles/volume] in Pleural fluid

234

2.19

6.41

1.3

mmol/l

3.5

3.4

0.04

210

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

140

887

1.59

6.32

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

302

2.03

6.31

1.1

iu/ml

3.8

3.5

—

(3004616) Nuclear Ab [Presence] in Serum

124

763

1.63

6.31

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

374

4861

0.76

6.29

1.7

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

224

1569

1.44

6.28

2.4

2.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

759

1.63

6.20

1.1

g/l

1.5

0.07

114

676

(21494815) CD4 cells/100 lymphocytes in Specimen

478

1.79

6.02

2.3

2.2

35.3

40.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

126

792

1.60

5.91

8.4

15.1

mmol/l

7.6

7.4

0.15

105

658

(3024980) IgG subclass 4 [Mass/volume] in Serum

150

982

1.54

5.90

1.6

1.5

g/l

0.8

0.01

109

742

(3012441) Differential panel - Pleural fluid

128

809

1.59

5.87

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

6142

59315

1.13

5.86

25.6

16.1

38.9

39.4

3.33

4124

40694

(3029075) Extractable nuclear Ab panel - Serum

160

2.38

5.86

1.0

1.1

—

(3035880) pH of Pleural fluid

410

1.84

5.83

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

477

3795

1.27

5.81

3.1

3.3

pmol/l

4.3

4.4

1.44

425

3340

(3022493) Free Hemoglobin [Mass/volume] in Plasma

271

2.04

5.80

1.4

5.2

mg/l

2874.2

67.1

0.53

192

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

326

1.94

5.79

3.2

3.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.01

5.79

5.0

5.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

104

627

1.67

5.77

1.6

1.4

e6/l

230815.7

172371.0

0.23

429

(1761868) Lipid panel - Serum or Plasma

1998

21998

0.88

5.75

3.1

3.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

978

8392

1.19

5.72

4.5

4.6

31.8

32.6

1.55

717

5570

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

237

1713

1.39

5.62

2.0

1.9

mg/l

12.6

11.7

0.59

216

1585

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

295

1.97

5.61

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

176

2.28

5.60

3.9

5.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

149

988

1.52

5.55

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.80

5.55

1.3

1.2

u/l

1822.7

72.9

0.50

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

417

1.81

5.55

2.1

2.6

e6/l

753.2

618.6

0.51

174

(40768806) Pleura Pathology biopsy report

129

829

1.56

5.54

1.4

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

5.24

5.52

1.0

1.1

—

26.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

107

658

1.63

5.51

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.49

5.50

1.1

1.6

—

(3047189) Immunofixation for 24 hour Urine

319

1.92

5.46

2.0

1.7

—

(3011412) CD3 cells [#/volume] in Blood

568

1.68

5.46

2.2

2.4

e9/l

1.0

1.2

0.55

345

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

427

1.79

5.44

1.0

mg/l

295.0

287.9

0.38

388

(3002619) Bacteria identified in Specimen by Culture

123

2.53

5.43

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

106

2.65

5.39

1.1

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

356

1.86

5.39

1.8

1.9

u/field

2.2

2.0

0.11

244

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

342

1.88

5.38

2.3

2.8

35.9

37.0

0.12

119

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

512

4147

1.25

5.37

2.4

au/ml

15.7

24.3

0.96

193

(3014148) Varicella zoster virus Ab [Titer] in Serum

101

617

1.64

5.36

1.1

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

5620

54103

1.12

5.31

29.7

18.0

14.1

13.8

50.69

5526

52837

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.92

5.29

2.3

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.34

5.29

4.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

206

1473

1.41

5.23

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

357

2777

1.30

5.22

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

113

715

1.59

5.21

1.3

u/l

612.4

404.7

0.53

104

667

(3023511) Choriogonadotropin [Units/volume] in Urine

576

1.66

5.20

1.5

1.3

—

(3011288) Drugs identified in Urine by Screen method

138

916

1.52

5.15

4.9

2.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

428

1.76

5.12

2.4

1.7

—

(3019977) pH of Arterial blood

407

1.78

5.08

3.0

2.7

7.4

0.09

142

(4198724)

184

2.18

5.07

2.2

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

489

1.70

5.07

1.7

1.5

promille

1.4

1.3

0.20

368

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

2.39

5.03

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

159

2.27

5.03

1.2

1.1

91.1

86.7

0.25

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

551

1.66

5.02

1.2

1.3

u/l

13.3

13.7

0.08

507

(3036670) Protein [Mass/volume] in Synovial fluid

206

2.09

4.93

1.3

1.2

g/l

39.7

38.9

0.13

110

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

609

1.62

4.89

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

156

1074

1.46

4.89

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

149

1017

1.47

4.88

1.7

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

194

2.12

4.86

2.5

1.9

e6/l

537.6

4960.0

0.54

129

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

112

2.51

4.86

4.4

3.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

369

1.79

4.84

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

469

3810

1.24

4.83

2.7

2.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

370

1.79

4.80

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

156

2.25

4.80

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

131

2.37

4.80

2.2

2.0

—

(3045716) Anion gap in Serum or Plasma

306

1.87

4.77

2.8

2.1

mmol/l

7.9

9.2

1.97

243

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.41

4.74

1.7

1.2

ml/s/173m2

0.5

1.0

1.62

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

180

1281

1.41

4.73

1.4

pmol/l

243.1

189.1

0.32

173

1242

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

350

1.81

4.73

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

463

3766

1.24

4.72

1.3

au/ml

44.3

54.8

0.24

177

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

158

1099

1.45

4.71

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

572

4758

1.22

4.71

2.3

2.1

nmol/l

11.0

12.7

4.93

495

4183

(3042517) Benzodiazepines panel - Urine

3.94

4.70

3.9

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

136

920

1.49

4.68

1.7

1.9

ug/l

17.8

24.1

2.32

131

899

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6630

64594

1.13

4.65

5.2

4.7

mmol/l

6.1

6.0

1.63

6045

58352

(3003694) ABO and Rh group [Type] in Blood

1907

17412

1.12

4.63

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

626

1.59

4.63

3.3

2.3

—

(3024471) HLA-A [Type]

179

2.13

4.58

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

275

1.90

4.57

1.8

2.1

umol/l

80.6

129.2

0.92

153

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.40

4.56

1.1

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

147

1016

1.45

4.55

2.6

2.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.56

4.54

1.3

1.2

mmol/l

1.4

1.8

0.13

(3024932) HLA-DR beta [Type]

174

2.13

4.48

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

996

8738

1.16

4.43

10.1

7.4

—

(3007461) Platelets [#/volume] in Blood

7426

72942

1.16

4.41

36.3

21.8

e9/l

243.7

248.2

6.60

7270

70847

(3023419) Bacteria identified in Sputum by Culture

129

875

1.48

4.40

2.7

2.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

244

1.93

4.37

1.4

2.0

191.5

150.8

2.11

228

(3044242) Glucose [Moles/volume] in Arterial blood

345

1.77

4.35

2.7

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

412

1.70

4.35

2.7

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

292

2271

1.30

4.34

1.7

—

(3024263) Appearance of Synovial fluid

353

1.76

4.32

1.6

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

125

2.32

4.32

1.3

1.4

g/l

26.8

28.0

0.13

(3032057) Clostridioides difficile [Presence] in Stool

157

2.17

4.32

1.8

1.7

—

(4062490)

614

1.57

4.30

1.4

1.3

—

(3024731) MCV [Entitic volume]

7427

72971

1.16

4.30

36.2

21.7

91.6

91.3

7.90

7336

71755

(3035941) MCH [Entitic mass]

7427

72971

1.16

4.30

36.1

21.7

30.3

30.4

3.77

7337

71756

(3006922) Hepatitis E virus Ab [Presence] in Serum

406

1.71

4.29

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

151

1063

1.43

4.26

1.3

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

7427

72979

1.16

4.26

36.3

21.8

e12/l

4.4

4.5

26.59

7256

70653

(3000963) Hemoglobin [Mass/volume] in Blood

7428

72992

1.16

4.25

36.5

21.9

g/l

132.1

134.8

43.15

7344

71783

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

168

1207

1.40

4.23

2.1

u/l

8280.2

4226.2

0.72

479

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

379

1.72

4.19

2.2

2.5

e9/l

0.2

0.38

333

(3010813) Leukocytes [#/volume] in Blood

7427

72992

1.16

4.19

36.3

21.8

e9/l

7.0

6.8

3.50

7259

70643

(3034891) Synovial lining cells/100 cells in Synovial fluid

298

1.82

4.19

1.5

3.0

3.9

0.40

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

115

771

1.50

4.17

1.7

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

228

1.93

4.13

1.3

1.4

5.2

1.8

0.96

192

(3027135) IgG subclass 1 [Mass/volume] in Serum

613

1.56

4.12

1.4

1.3

g/l

6.8

6.6

0.17

428

(3028192) IgG subclass 2 [Mass/volume] in Serum

613

1.56

4.12

1.4

1.3

g/l

3.0

2.8

0.42

429

(3024139) IgG subclass 3 [Mass/volume] in Serum

613

1.56

4.12

1.4

1.3

g/l

0.4

0.19

427

(3009214) Lutropin [Units/volume] in Serum or Plasma

185

1360

1.37

4.07

1.4

1.3

u/l

12.2

11.0

0.46

157

1104

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.52

4.04

1.6

2.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.50

4.03

11.8

10.6

mmol/l

6.7

5.5

0.49

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.93

4.00

4.3

3.5

mg/l

0.9

1.1

0.33

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

392

1.69

4.00

2.1

2.5

e6/l

527.5

512.2

0.08

332

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

207

1557

1.34

3.94

1.1

u/ml

5.7

8.9

0.71

170

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

117

798

1.47

3.93

2.4

u/ml

18.6

856.1

1.41

117

773

(4024509)

101

669

1.52

3.91

1.6

—

(3051651) Icteric interference index of Serum or Plasma

418

1.66

3.89

4.0

3.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

622

1.53

3.88

2.3

2.2

u/field

1.3

2.0

0.62

216

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

101

2.38

3.80

1.4

1.2

ng/l

161.8

118.0

0.22

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.48

3.79

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.48

3.79

1.0

1.2

—

(3007463) Buprenorphine [Presence] in Urine

8.76

3.77

3.6

2.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

153

2.10

3.77

1.3

1.2

84.2

85.3

0.05

(3035320) C reactive protein [Mass/volume] in Body fluid

453

1.62

3.76

3.4

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

438

1.63

3.75

2.1

2.0

16.1

14.2

0.41

184

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2624

24599

1.10

3.73

5.1

5.0

ug/l

4.3

3.3

0.50

2355

22026

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

213

1625

1.32

3.70

1.3

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

148

2.10

3.67

2.6

2.0

mg/l

9.0

9.7

0.27

120

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

365

1.68

3.63

3.0

3.7

—

(21494755) Public health laboratory ask at order entry panel

412

4952

0.82

3.63

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

3.62

1.1

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

114

788

1.45

3.61

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

101

682

1.49

3.60

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

198

1502

1.33

3.59

5.0

3.6

mg/l

29.0

28.7

0.04

126

953

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

546

1.54

3.58

1.4

u/l

13.7

13.0

0.24

522

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

234

1.84

3.54

3.5

2.8

umol/l

28.9

28.6

0.07

172

(3011648) Oxygen content in Venous blood

524

1.55

3.53

2.2

2.0

11.8

11.0

0.78

524

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.81

3.51

1.1

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

385

1.64

3.48

1.6

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

106

729

1.46

3.46

3.9

3.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

173

1297

1.34

3.42

2.7

1.7

nmol/l

0.9

0.8

1.52

143

1076

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

389

1.62

3.35

1.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

138

1002

1.38

3.35

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.72

3.34

3.9

4.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

134

2.09

3.32

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.72

3.31

1.1

1.2

u/ml

0.0

0.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.72

3.31

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

3.31

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.41

3.29

1.2

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

449

3786

1.20

3.29

1.2

iu/ml

94.8

138.3

2.28

156

1404

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

102

2.26

3.28

1.2

92.0

73.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

170

1.94

3.22

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.24

3.21

1.2

78.3

70.6

—

(3012565) Volume of 24 hour Urine

325

1.67

3.19

2.8

2.3

1663.8

1900.2

0.89

281

(3013166) Neutrophils/100 leukocytes in Synovial fluid

200

1.85

3.15

1.7

1.3

54.8

55.3

0.03

168

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.68

3.05

7.1

5.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

174

1.90

3.03

2.4

1.7

e6/l

13344.7

11721.5

0.05

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

441

1.55

2.99

1.6

1.4

—

(40757373) Influenza virus identified in Isolate

134

2.02

2.95

1.9

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

485

4161

1.18

2.94

1.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

227

1.77

2.93

2.3

1.9

ug/l

65.1

52.6

0.35

222

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

437

3718

1.19

2.93

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

420

1.55

2.91

2.1

2.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

288

1.67

2.90

2.1

1.3

umol/l

21.6

24.5

0.31

275

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

469

1.52

2.88

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

129

2.02

2.85

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

126

929

1.36

2.84

1.3

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

327

2720

1.21

2.82

1.1

titre

—

198.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.45

2.79

1.0

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

276

1.67

2.79

1.3

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.46

2.78

5.5

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.92

2.77

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.26

2.76

4.8

5.5

ug/min

54.9

47.7

0.22

(3034274) Bile acid [Moles/volume] in Serum --fasting

427

1.53

2.73

2.2

1.8

umol/l

8.0

8.3

0.04

295

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

682

1.41

2.72

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.71

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

2.50

2.69

2.3

2.7

umol/l

354.9

583.4

0.29

(3044290) Cell count panel - Cerebral spinal fluid

158

1216

1.31

2.69

1.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

101

727

1.39

2.66

1.2

u/l

60.9

65.2

0.26

472

(3019832) Treponema pallidum Ab [Presence] in Serum

406

3465

1.18

2.66

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

127

949

1.34

2.65

1.1

iu/ml

24.7

11952.8

0.55

199

(3026692) Albumin [Mass/volume] in Peritoneal fluid

133

1.96

2.64

1.6

1.4

g/l

14.9

13.9

0.19

102

(3036603) Volume of Urine

463

1.49

2.63

1.7

1.6

1550.2

1892.7

1.48

124

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

114

839

1.36

2.63

1.1

au/ml

15.1

11.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.21

2.63

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

162

1.85

2.61

2.3

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.67

2.59

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

345

1.57

2.58

3.1

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

185

1.79

2.56

2.5

3.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

149

1.88

2.55

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

230

1.70

2.54

1.8

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

686

0.62

2.49

3.5

2.9

mg/l

105.1

52.0

0.86

508

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

339

2868

1.19

2.48

1.1

—

(3004451) EKG impression Narrative

349

1.55

2.47

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

454

1.48

2.46

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

815

1.35

2.46

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.38

2.46

1.9

1.5

umol/l

45.7

43.5

0.11

(3047007) Chlamydophila sp Ab [Presence] in Serum

108

799

1.36

2.44

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.24

2.43

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

530

1.44

2.42

1.5

1.6

u/ml

17.7

22.7

0.54

123

(3016879) Cocaine [Presence] in Urine

164

1290

1.28

2.40

3.0

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1269

0.73

2.40

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

188

1504

1.26

2.39

1.6

1.8

iu/l

4.2

4.6

0.17

519

(3003338) MCHC [Mass/volume]

5645

55141

1.07

2.39

31.6

19.3

g/l

330.2

332.1

45.24

5602

54647

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

220

1.68

2.37

2.3

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

220

1.68

2.37

2.3

2.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

141

1090

1.30

2.36

2.9

1.8

—

(3048879) Bone marrow aspiration report

213

1.69

2.35

1.9

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

183

1.75

2.34

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.15

2.34

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

252

2087

1.21

2.33

1.3

iu/l

34.9

32.4

0.50

216

1799

(3000764) Benzodiazepines [Presence] in Urine

174

1386

1.26

2.31

2.9

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

168

1334

1.26

2.29

1.3

mmol/l

3.8

3.9

0.48

154

1250

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

470

1.45

2.29

1.2

1.4

mmol/l

2.3

2.1

0.71

441

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

324

1.55

2.28

1.1

—

(3028300) Cannabinoids [Presence] in Urine

175

1398

1.26

2.27

3.0

1.8

—

(3003129) Base excess in Capillary blood by calculation

193

1.71

2.25

1.3

1.8

mmol/l

0.4

0.7

0.25

177

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.89

2.25

1.6

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.89

2.25

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

515

1.42

2.21

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

449

1.45

2.20

1.8

1.5

u/l

5.3

6.4

0.26

201

(3041918) Cholesterol [Moles/volume] in Pleural fluid

143

1.82

2.18

1.2

mmol/l

2.1

1.7

0.44

(3045424) Erythrocytes [Presence] in Urine

141

1104

1.28

2.17

1.6

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

122

1.89

2.15

1.7

1.5

ng/l

153.1

128.6

0.20

122

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.69

2.15

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.16

2.14

1.2

mmol/l

6.8

6.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

362

1.49

2.13

1.5

1.3

nmol/l

1.5

1.2

0.82

281

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

159

1.76

2.12

1.6

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

246

2055

1.20

2.12

6.2

4.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

167

1.74

2.10

1.3

1.2

32.2

34.0

0.09

110

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

145

1.80

2.09

2.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

589

1.38

2.08

1.4

1.2

nmol/l

1.6

1.5

0.40

526

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

438

1.44

2.08

1.3

titre

28.0

63.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

166

1334

1.25

2.08

1.4

e6/l

2464.6

1173.7

0.42

145

1084

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

340

1.50

2.08

1.0

1.1

iu/ml

5.6

10.3

1.70

(3027944) Amphetamines [Presence] in Urine

170

1371

1.24

2.07

2.9

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

117

1.88

2.05

1.1

1.3

—

(40768441) Liver Pathology biopsy report

432

1.44

2.03

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

592

1.37

2.03

1.2

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

125

1.84

2.02

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

147

1.77

2.01

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

186

1520

1.23

2.01

1.3

mg/l

524.4

540.6

0.18

178

1441

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.63

2.00

4.8

8.8

—

(3027008) Opiates [Presence] in Urine

172

1395

1.24

2.00

2.9

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

376

1.47

2.00

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

104

1.93

1.99

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

166

2042

0.81

1.99

1.8

1.7

mg/l

3.2

3.9

0.82

136

1441

(3033799) Differential panel - Peritoneal fluid

179

1.68

1.94

2.6

1.6

—

(3001729) Color of Synovial fluid

2.19

1.94

2.1

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

195

1.64

1.92

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.11

1.92

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

203

1.63

1.91

1.8

2.0

15.2

11.2

0.47

184

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

455

1.41

1.90

1.3

titre

51.7

300.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

414

1.43

1.89

1.1

1.2

mg/l

41.6

42.1

0.03

344

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

164

1333

1.23

1.89

1.3

1.4

e6/l

43.2

22.4

0.33

133

1028

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

143

1.75

1.88

1.9

2.0

ug/l

1.6

2.3

1.08

(21494814) CD8 cells/100 lymphocytes in Specimen

244

1.56

1.86

2.4

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

245

1.55

1.83

2.3

1.4

umol/l

27.8

29.9

0.58

235

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

477

1.39

1.80

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.34

1.77

2.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

395

1.42

1.76

1.1

mg/l

267.5

276.6

0.12

342

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

395

1.42

1.76

1.4

1.3

u/ml

3.0

1.4

0.54

197

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

1.75

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.93

1.74

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.73

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

515

1.36

1.73

1.3

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.13

1.71

1.1

1.4

ug/l

62.8

121.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.13

1.71

1.0

u/ml

0.0

1.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

194

1.60

1.71

1.4

1.3

21.0

21.5

0.03

162

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

194

1.60

1.71

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

202

1.59

1.70

1.7

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

769

1.29

1.70

1.1

u/ml

5.9

3.3

0.35

332

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.38

1.67

1.0

—

(3016228) CD19 cells/100 cells in Blood

253

1.50

1.62

2.4

2.0

5.9

8.9

1.34

244

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

540

1.34

1.60

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.87

1.60

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.33

1.60

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6343

62494

1.06

1.59

4.3

4.0

mmol/l

1.4

1.3

10.09

5762

56562

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

159

1.64

1.58

3.0

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

682

1.29

1.56

3.6

—

(3020491) Glucose [Moles/volume] in Blood

502

1.34

1.51

2.6

2.1

mmol/l

8.3

6.8

1.27

339

(3021387) Prolactin [Units/volume] in Serum or Plasma

183

1544

1.19

1.51

1.6

1.7

mu/l

287.1

299.7

0.28

171

1409

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.86

1.50

1.1

1.2

—

(3000012) Reticulocyte production index

409

1.37

1.49

1.6

1.5

—

(4281824)

688

1.28

1.48

1.2

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.13

1.44

1.8

nmol/l

182.2

201.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

396

1.37

1.41

1.8

2.4

umol/l

12.5

30.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

141

1.63

1.41

2.0

2.4

au/ml

176.9

151.3

—

(3017509) Phencyclidine [Presence] in Urine

2.18

1.39

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

165

1.58

1.39

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.89

1.38

2.9

2.8

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.77

1.38

1.5

1.8

pmol/l

31.1

50.3

0.83

(3020393) Adenovirus Ag [Presence] in Stool

2.00

1.38

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

166

1.57

1.36

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

166

1.57

1.36

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

166

1.57

1.36

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

166

1.57

1.36

1.0

1.1

—

(3013762) Body weight Measured

2.94

1.36

1.8

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

248

1.45

1.34

1.1

u/ml

10.0

4.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

191

1.52

1.34

1.4

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

183

1.53

1.34

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

167

1.56

1.34

1.3

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.04

1.32

1.1

u/l

21.1

15.3

0.14

(3036048) Francisella tularensis Ab [Titer] in Serum

136

1.62

1.32

1.3

1.1

—

622.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

233

2663

0.87

1.30

1.6

1.7

—

(40765096) Chromosome analysis panel by Banding

193

1.50

1.29

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

517

1.30

1.28

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.00

1.27

1.7

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

302

1.39

1.26

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

170

1.53

1.25

1.1

—

(3023410) Appearance of Cerebral spinal fluid

572

1.28

1.25

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

581

1.28

1.24

1.1

—

79.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.40

1.24

2.2

2.0

mg/l

1.9

2.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

131

1.60

1.23

1.5

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

321

1.37

1.22

1.1

1.7

—

(3025315) Body weight

2.04

1.21

4.1

3.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

204

1.47

1.21

2.3

2.0

—

(40762814) Titanium [Mass/volume] in Blood

124

1.61

1.20

2.1

2.3

ug/l

2.6

4.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

263

0.61

1.19

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

324

1.36

1.17

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

623

1.25

1.16

1.3

1.4

—

(40760409) HLA-A [Type] by High resolution

2.50

1.15

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.50

1.15

1.0

—

(40763590) HLA-DQ beta [Type]

2.50

1.15

1.0

—

(40760410) HLA-B [Type] by High resolution

2.50

1.15

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.05

1.15

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

1.50

1.15

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

607

1.25

1.14

1.1

—

3.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

495

0.73

1.13

1.0

ng/l

45.6

43.5

0.14

337

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.75

1.12

1.1

1.2

u/l

32.1

19.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.00

1.12

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

167

1.50

1.12

1.8

1.5

ug/l

9.3

0.02

167

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

327

1.35

1.11

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1477

14129

1.06

1.11

3.0

3.1

ug/l

0.8

0.50

1074

9597

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.54

1.11

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

259

1.39

1.11

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

493

0.73

1.10

1.0

ng/l

728.0

712.0

0.11

334

(3030313) Adrenal Ab [Titer] in Serum

2.26

1.10

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

251

1.40

1.10

2.3

2.1

ug/l

18.8

172.0

0.76

233

(3003740) Influenza virus B Ag [Presence] in Specimen

773

1.22

1.09

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

773

1.22

1.09

1.1

—

(3013862) HLA-DP [Type]

2.38

1.09

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.73

1.08

9.4

12.0

—

(3003181) Sodium [Moles/volume] in Urine

148

1270

1.17

1.08

1.4

1.3

mmol/l

63.9

62.8

0.12

107

1010

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

490

0.73

1.07

1.0

ng/l

361.2

321.6

0.33

342

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

169

1.48

1.06

1.1

1.3

nmol/l

111.1

133.9

0.42

124

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.65

1.06

2.4

2.0

umol/l

15.3

18.0

0.44

(1002224) Polysomnography panel

266

2382

1.12

1.05

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

590

0.76

1.04

1.6

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.27

1.03

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

1.34

1.02

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

147

1.50

1.00

1.8

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

396

1.29

0.98

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.84

0.98

1.6

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

173

1.45

0.97

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.85

0.96

4.9

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

224

1.39

0.96

1.4

1.5

pmol/l

16.3

16.5

0.08

189

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.89

0.94

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

480

1.25

0.93

1.3

mmol/l

12.7

11.6

0.26

136

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2039

19748

1.04

0.93

4.4

21.5

21.9

0.54

1043

9895

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.73

0.92

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.92

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.60

0.90

1.7

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

340

1.30

0.90

1.1

—

(4027681)

305

1.31

0.90

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.07

0.89

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.07

0.89

18.2

7.2

—

(3006270) Folate [Moles/volume] in Blood

638

1.21

0.88

1.2

nmol/l

273.9

339.2

2.20

513

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1801

17419

1.04

0.88

1.7

1.6

mmol/l

1.5

1.4

3.39

1515

14489

(3014599) Egg white IgE Ab [Units/volume] in Serum

277

0.69

0.87

1.1

1.0

u/ml

1.2

0.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.61

0.87

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.61

0.87

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

229

1.36

0.86

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.78

0.84

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.59

0.84

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

283

1.31

0.83

1.4

60.6

66.1

0.40

234

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

111

1283

0.86

0.82

1.5

—

(3025130) Human papilloma virus identified in Specimen

662

1.20

0.82

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.81

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

566

0.79

0.81

1.0

1.1

u/ml

3.3

3.6

0.05

199

(3014133) Dog dander IgE Ab [Units/volume] in Serum

610

0.80

1.1

u/ml

3.6

3.0

0.08

221

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

285

1.30

0.79

1.1

u/l

1.0

1.1

1.08

138

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

224

1.34

0.79

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.82

0.79

1.5

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

233

1.33

0.79

1.1

miu/ml

1389.1

1494.7

0.26

233

(3038177) Helicobacter pylori Ab [Presence] in Serum

114

990

1.15

0.78

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

384

1.25

0.78

1.1

nmol/l

7.1

6.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6520

64642

1.04

0.77

4.7

4.5

mmol/l

1.4

1.5

18.40

5979

58982

(4034850)

239

2175

1.10

0.76

13.4

10.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.77

0.76

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6571

65166

1.04

0.75

4.8

4.5

mmol/l

4.5

4.6

4.98

6066

59829

(3026470) Cobalt [Mass/volume] in Blood

449

1.23

0.75

1.8

1.9

ug/l

4.5

3.5

0.46

394

(3025577) Chromium [Mass/volume] in Blood

440

1.23

0.75

1.8

2.0

ug/l

2.9

2.4

0.33

369

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.60

0.74

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

387

1.24

0.74

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

254

1.30

0.73

1.1

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

277

0.72

1.1

1.0

u/ml

0.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

0.72

1.0

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

446

0.78

0.72

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.52

0.72

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

142

1.41

0.72

1.4

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

276

0.72

0.71

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

456

4280

1.07

0.71

1.3

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.71

0.70

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.85

0.68

1.8

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

384

1.23

0.66

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

1.36

0.66

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

111

1.44

0.65

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

531

1.19

0.65

3.5

5.2

u/ml

94.4

86.0

0.05

155

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

171

1.35

0.65

1.1

1.3

—

(40758358) Immune stain study

1.72

0.64

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

166

1507

1.10

0.60

3.1

nmol/l

0.8

1.18

128

1144

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.60

0.0

3.0

—

11.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

1.37

0.60

1.2

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.54

0.59

1.0

—

4.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.51

0.58

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

140

1.36

0.58

1.9

2.0

e6/l

98.6

1334.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.48

0.57

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

196

0.71

0.57

1.5

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.67

0.56

1.0

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.54

0.55

1.1

1.3

pmol/l

18.6

21.4

—

(3016038) Potassium [Moles/volume] in Urine

467

1.18

0.55

1.2

1.1

mmol/l

31.8

35.1

0.49

391

(3013293) Extractable nuclear Ab [Presence] in Serum

1.45

0.55

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

366

1.20

0.55

1.2

1.4

ug/l

2.0

4.2

1.79

306

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.58

0.54

1.2

1.0

—

(3014891) Appearance of Pleural fluid

117

1.37

0.52

1.4

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

379

1.19

0.50

2.2

ug/min

210.7

94.7

0.40

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.46

0.50

1.2

—

(3016750) Collection duration of Urine

398

1.18

0.50

2.4

2.1

min

487.2

494.9

0.22

294

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

163

1773

0.92

0.50

1.4

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

171

1.29

0.49

8.8

7.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

198

1.26

0.49

2.2

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

699

1.13

0.48

1.4

1.3

u/l

25.9

30.7

0.76

559

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.47

0.47

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

227

1.23

0.46

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

282

1.21

0.46

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.59

0.45

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

147

1.29

0.45

8.8

8.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

302

1.19

0.44

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.61

0.43

1.4

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.56

0.42

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

258

1.20

0.41

4.1

2.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

11950.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

123

1.30

0.40

1.3

1.5

10.2

11.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.25

0.40

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

529

0.87

0.40

2.2

1.8

—

(3012898) Urea [Moles/volume] in Urine

1.31

0.39

1.5

1.2

mmol/l

140.5

154.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

102

0.69

0.39

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

823

0.90

0.39

1.5

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.37

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

557

0.88

0.37

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

170

1.24

0.37

1.7

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

216

1.20

0.36

1.5

mmol/l

8.8

8.2

0.27

122

(40768795) Lymph node Pathology biopsy report

658

1.11

0.36

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

235

1.19

0.36

1.1

ng/l

196.6

266.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.43

0.35

1.7

1.3

nmol/l

5.4

4.8

—

(3005033) Fetal Nuchal fold Thickness US

554

0.88

0.35

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6695

66653

1.02

0.35

5.3

5.0

mmol/l

2.7

3.24

6134

60891

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

573

0.89

0.33

1.4

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

219

1.19

0.33

1.2

1.3

ug/l

1228.9

286.3

0.43

117

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

729

0.90

0.32

1.4

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

147

1.22

0.30

1.2

1.1

umol/24h

0.6

0.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

129

1207

1.07

0.30

2.0

1.8

pmol/l

185.4

202.5

1.33

119

1129

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

150

1413

1.06

0.29

1.3

miu/ml

181.0

218.4

0.55

617

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

786

0.92

0.29

1.4

1.2

mmol/l

7.3

7.6

0.24

573

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

122

1.23

0.27

4.7

8.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

366

1.12

0.26

1.2

1.1

u/l

32.0

28.6

0.11

272

(4212803)

1.19

0.26

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.26

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

367

1.12

0.25

1.2

1.1

u/l

93.1

89.4

0.08

284

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

221

2117

1.05

0.25

2.1

1.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

160

1.19

0.25

1.1

1.2

pmol/l

311.0

289.9

0.12

117

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

174

1659

1.05

0.24

2.0

1.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

133

1.20

0.24

3.4

5.1

u/l

30.0

73.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

821

8372

0.98

0.23

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.32

0.23

1.4

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

144

1.18

0.22

1.6

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

679

0.93

0.21

1.4

—

(3011985) Renin [Units/volume] in Plasma

914

1.06

0.21

1.4

mu/l

52.5

57.9

0.16

823

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

123.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

678

0.93

0.21

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

1062

1.06

0.20

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

677

0.93

0.20

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

676

0.93

0.20

1.4

—

(4094501)

178

1852

0.96

0.20

1.1

—

(40768800) Prostate Pathology biopsy report

151

1576

0.96

0.19

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.15

0.19

1.3

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

666

1.07

0.19

1.4

nmol/l

0.5

0.3

0.33

505

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.23

0.18

2.4

2.8

u/field

0.5

0.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.17

0.17

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

185

1915

0.97

0.17

1.6

1.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.11

0.17

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

194

0.88

0.16

2.1

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

360

0.92

0.16

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

496

1.07

0.16

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

318

0.91

0.15

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.79

0.15

2.0

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.13

0.15

1.3

1.2

mg/l

10.5

10.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.13

0.15

1.8

1.7

—

(3000285) Sodium [Moles/volume] in Blood

102

1.18

0.15

1.4

1.1

—

(44806420)

237

1.10

0.14

2.3

2.4

—

(37021550) Renin [Units/volume] in Plasma --upright

151

1.13

0.13

1.1

1.3

mu/l

68.8

77.0

0.10

109

(4146454)

784

1.05

0.13

2.3

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

159

1548

1.03

0.11

1.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.11

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

799

0.96

0.10

1.0

1.1

u/ml

2.5

3.7

0.76

374

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

434

4399

0.99

0.10

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.11

0.09

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

766

0.97

0.09

1.0

1.1

u/ml

0.6

0.9

0.55

302

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

857

0.97

0.08

1.4

1.3

pmol/l

269.9

311.2

0.45

649

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.09

0.08

1.3

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.84

0.07

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.86

0.07

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.83

0.07

1.2

umol/24h

2.1

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

163

0.92

0.07

1.3

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

842

0.97

0.06

1.3

nmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

679

6838

0.99

0.06

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

384

1.04

0.06

4.6

6.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

345

1.04

0.06

1.5

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

131

0.92

0.05

1.2

1.3

nmol/l

27.6

31.3

0.21

107

(3010726) Horse dander IgE Ab [Units/volume] in Serum

698

0.97

0.05

1.0

1.1

u/ml

2.1

0.01

156

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

174

1765

0.99

0.05

2.6

2.3

ug/min

149.7

91.7

0.65

103

1048

(40768793) Breast Pathology biopsy report

147

1447

1.02

0.05

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

198

1.06

0.05

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

297

1.04

0.05

6.0

5.0

u/ml

57.5

658.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

181

0.94

0.05

1.7

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

150

1.07

0.04

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

150

1.07

0.04

5.9

6.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

886

0.98

0.04

1.1

u/ml

0.7

1.5

1.33

335

(3028679) Herpes simplex virus Ab [Presence] in Serum

279

1.04

0.04

1.3

1.2

—

(4133840)

171

1.05

0.03

1.2

—

(3004775) Volume in Urine collected for unspecified duration

580

1.02

0.02

2.4

2.2

741.1

644.5

1.36

381

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

182

1.04

0.02

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

499

0.98

0.02

1.0

u/ml

0.7

0.2

—

114

(3008295) Osmolality of Serum or Plasma

689

0.99

0.01

1.8

1.3

mosm/kgh2o

286.7

278.3

1.98

527

(3020650) Glucose [Presence] in Urine

154

0.97

0.00

1.2

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

216

1.02

0.00

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

873

1.00

0.00

1.2

1.3

—

(44813793)

386

1.01

0.00

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

445

0.99

0.00

1.4

pmol/l

762.4

65.0

0.61

136

(3006462) Nitrate [Presence] in Urine

348

1.01

0.00

4.3

3.4

—

(4211845)

381

1.00

0.00

4.1

3.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

281

1.00

0.00

1.8

1.7

nmol/l

4.0

5.8

0.26

234

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.6

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.99

0.00

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.90

0.00

1.0

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.96

0.00

1.0

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.92

0.00

5.7

6.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.5

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.92

0.00

2.8

3.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

3.0

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.99

0.00

1.1

2.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.02

0.00

1.0

5.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

130

1.00

0.00

1.1

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_PHLETHROMBDVTLOW and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_PHLETHROMBDVTLOW	1.956 [1.79, 2.14]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.174

During the follow-up period (1.1.1998 — 31.12.2019), 8481 out of 23064 females with I9_PHLETHROMBDVTLOW died.

Males

Parameter	HR [95% CI]	p-value
I9_PHLETHROMBDVTLOW	1.787 [1.62, 1.97]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 6539 out of 19493 males with I9_PHLETHROMBDVTLOW died.

Mortality risk

Mortality risk for people of age

years, who have I9_PHLETHROMBDVTLOW.

N-year risk	Females	Males
1	0.157%	0.291%
5	1.053%	1.943%
10	2.745%	4.865%
15	5.114%	9.035%
20	9.384%	15.535%

Relationships between endpoints

↥

Index endpoint: I9_PHLETHROMBDVTLOW – DVT of lower extremities

GWS hits: 26

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

DVT of lower extremities

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints